Pages that link to "Q34453019"

The following pages link to Acquired tamoxifen resistance in human breast cancer–potential mechanisms and clinical implications (Q34453019):

Displaying 42 items.

• Endocrinology and hormone therapy in breast cancer: selective oestrogen receptor modulators and downregulators for breast cancer - have they lost their way? (Q24810287) (← links)
• Antiestrogens: structure-activity relationships and use in breast cancer treatment (Q28077245) (← links)
• Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance (Q28141690) (← links)
• Involvement of R-Ras and Ral GTPases in estrogen-independent proliferation of breast cancer cells (Q28208373) (← links)
• Constitutively nuclear FOXO3a localization predicts poor survival and promotes Akt phosphorylation in breast cancer (Q28475229) (← links)
• Breast cancer (metastatic). (Q33448016) (← links)
• The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers (Q34119671) (← links)
• ACK1 tyrosine kinase interacts with histone demethylase KDM3A to regulate the mammary tumor oncogene HOXA1 (Q34317299) (← links)
• Arzoxifene: the evidence for its development in the management of breast cancer (Q34449901) (← links)
• Nordamnacanthal potentiates the cytotoxic effects of tamoxifen in human breast cancer cells. (Q34583778) (← links)
• Estrogen enhances the efficacy of an oncolytic HSV-1 mutant in the treatment of estrogen receptor-positive breast cancer (Q34601083) (← links)
• Exemestane: a potent irreversible aromatase inactivator and a promising advance in breast cancer treatment (Q34734021) (← links)
• Mechanisms of Gefitinib-mediated reversal of tamoxifen resistance in MCF-7 breast cancer cells by inducing ERα re-expression (Q35040890) (← links)
• Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a potential new therapeutic approach (Q35134342) (← links)
• Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells (Q35558138) (← links)
• Macrophage-elicited loss of estrogen receptor-α in breast cancer cells via involvement of MAPK and c-Jun at the ESR1 genomic locus. (Q35571726) (← links)
• Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity (Q35757179) (← links)
• Role of SUMOylation in full antiestrogenicity (Q36277244) (← links)
• Cytotoxicity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cells (Q37044225) (← links)
• Interrogating the genome to understand oestrogen-receptor-mediated transcription (Q37123646) (← links)
• Rational management of endocrine resistance in breast cancer: a comprehensive review of estrogen receptor biology, treatment options, and future directions. (Q37279990) (← links)
• Green synthesis of silver nanoparticles using Ganoderma neo-japonicum Imazeki: a potential cytotoxic agent against breast cancer cells. (Q37323343) (← links)
• ER re-expression and re-sensitization to endocrine therapies in ER-negative breast cancers (Q37407136) (← links)
• Lantana camara Linn root extract-mediated gold nanoparticles and their in vitro antioxidant and cytotoxic potentials (Q38722423) (← links)
• Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression (Q39262372) (← links)
• A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells. (Q40171629) (← links)
• Solution structure and antiestrogenic activity of the unique C-terminal, NR-box motif-containing region of MTA1s. (Q40261676) (← links)
• Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway. (Q40635044) (← links)
• Cellular uptake and concentrations of tamoxifen upon administration in poly(epsilon-caprolactone) nanoparticles (Q42129363) (← links)
• Biomonitoring of urinary tamoxifen and its metabolites from breast cancer patients using nonaqueous capillary electrophoresis with electrospray mass spectrometry (Q43729839) (← links)
• Biodegradable poly(epsilon -caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen (Q43770733) (← links)
• (-)-Epigallocatechin (EGC) of green tea induces apoptosis of human breast cancer cells but not of their normal counterparts. (Q44236306) (← links)
• Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen (Q45099758) (← links)
• Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state (Q50668328) (← links)
• Acquired antiestrogen resistance in MCF-7 human breast cancer sublines is not accomplished by altered expression of receptors in the ErbB-family. (Q54065729) (← links)
• (Q56602559) (redirect page) (← links)
• Breast cancer (metastatic) (Q57139202) (← links)
• Illuminating the Anticancerous Efficacy of a New Fungal Chassis for Silver Nanoparticle Synthesis (Q64244310) (← links)
• TARBP2-Enhanced Resistance during Tamoxifen Treatment in Breast Cancer (Q64245900) (← links)
• Diphenyl quinolines and isoquinolines: synthesis and primary biological evaluation (Q73226598) (← links)
• Selection of metastatic tumour phenotypes by host immune systems (Q73327119) (← links)
• Investigating the effect of visfatin on ERalpha phosphorylation (Ser118 and Ser167) and ERE-dependent transcriptional activity (Q90400862) (← links)